drugset / Trial / NCT06797674

A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)

NCT06797674

Phase 1 Completed 34 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of the study is to learn what happens to levels of MK-7602 in a healthy person's body over time. Researchers will compare what happens to MK-7602 in the body when it is given with or without another medicine called efavirenz, and when it is given with or without a meal.

Timeline

Start
2025-02-10
Primary completion
2025-08-12
Completion
2025-08-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified
Subject MK-7602 Unknown

Indications

No indication recorded.